| Vol. 9.35 – 7 September, 2021 |
| |
|
|
| Researchers studied CD8 T cells in patients with human papillomavirus (HPV)-positive head and neck cancer and identified several epitopes derived from HPV E2, E5 and E6 proteins that allowed them to analyze virus-specific CD8 T cells using major histocompatibility complex class I tetramers. [Nature] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Investigators engineered CAR-T cells to deliver RN7SL1, an endogenous RNA that activates RIG-I/MDA5 signaling. RN7SL1 promoted expansion and effector-memory differentiation of CAR-T cells. [Cell] |
|
|
|
| Through multiplexed single-cell mRNA sequencing, the authors identified cKit+CD127hiTCF-1hi early differentiation stages of T-bet+ innate lymphoid cells. [Nature Immunology] |
|
|
|
| The authors found that a small number of TCF1+ tumor-specific CD8+ T cells were present in lung tumors throughout their development. [Science Immunology] |
|
|
|
| Using multiplex immunofluorescence staining in cohorts of anti-PD-1 and anti-PD-L1-treated lung cancer patients, scientists showed that decreased expression of cancer cell αV was associated with improved immunotherapy-related, progression-free survival. [Nature Communications] |
|
|
|
| The average survival time was shorter in patients with JAK/STAT and PHF6 comutation than that in other patients, suggesting a potential role of PHF6 in leukemia progression. [Leukemia] |
|
|
|
| Monocytes from stressed mice and humans exhibit a characteristic inflammatory transcriptomic signature and are hyperresponsive upon stimulation with Toll-like receptor ligands. [Cell Reports] |
|
|
|
| Investigators found that pharmacologic inhibition of neddylation using a small-molecule inhibitor, MLN4924/Pevonedistat, increased the expression of the natural killer (NK) cell-activating receptor NKG2D ligands MICA and MICB on the plasma membrane of different multiple myeloma cell lines and patient-derived plasma cells, leading to enhanced NK cell degranulation. [Cell Death & Disease] |
|
|
|
| Scientists aimed to investigate the role of MAPK signaling in childhood asthma and its environment-mediated protection, including a representative selection of 232 out of 1062 children from two cross-sectional cohorts and one birth cohort study. [Pediatric Allergy and Immunology] |
|
|
|
|
| The authors discuss the role of inflammation in initiating epigenetic alterations in immune cells, cancer-associated fibroblasts, and cancer cells and suggest how and when epigenetic interventions can be combined with immunotherapies to improve therapeutic outcomes. [Cellular & Molecular Immunology] |
|
|
|
| Scientists summarize recent findings related to intestinal dendritic cells in steady state and upon inflammation, with a special focus on their functional specializations, highly dependent on their microenvironment. [Mucosal Immunology] |
|
|
|
|
| Two National Institute of Health (NIH) grants totaling over $1.3 million will enable research into antibody-mediated drug delivery technology for the treatment of cancer and autoimmune disorders. L. Nathan Tumeyis the Principal Investigator on both grants — $1.2 million from the National Institute of General Medical Sciences and $150,000 from the National Institute of Allergy and Infectious Diseases. [Bringhamton University] |
|
|
|
| Brickell Biotech, Inc. announced it has entered into a definitive agreement with Voronoi, Inc. that grants Brickell exclusive, worldwide rights to research, develop and commercialize novel therapeutics generated from a proprietary DYRK1A inhibitor platform. [Brickell Biotech, Inc.] |
|
|
|
|
| October 14 – 15, 2021 London, England, United Kingdom |
|
|
|
|
|
| Benaroya Research Institute at Virginia Mason – Seattle, Washington, United States |
|
|
|
| University Hospital of Bern – Bern, Switzerland |
|
|
|
| The University of Tennessee Health Science Center – Memphis, Tennessee, United States |
|
|
|
| University of Colorado – Aurora, Colorado, United States |
|
|
|
| University of Miami – Miami, Florida, United States |
|
|
|
|